title: The in vivo comet assay: use and status in genotoxicity testing.
abstract: The in vivo comet assay (single cell gel electrophoresis assay) in its alkaline version (pH >13) is being increasingly used in genotoxicity testing of substances such as industrial chemicals, biocides, agrochemicals, food additives and pharmaceuticals. Recommendations for an appropriate performance of the test using OECD guidelines for other in vivo genotoxicity tests have been published. In this review, we critically discuss the biological significance of comet assay effects in general and the status of the test in current strategies for genotoxicity testing. Examples for practical applications of the in vivo comet assay and potential consequences of positive and negative test results are given. The significance of comet assay results for hazard identification and risk assessment is discussed. In accordance with international guidelines for genotoxicity testing the in vivo comet assay is recommended for follow-up testing of positive in vitro findings. It is particularly useful as a tool for the evaluation of local genotoxicity, especially for organs/cell types which cannot easily be evaluated with other standard tests. A positive result in an appropriately performed in vivo comet assay indicates genotoxicity of the test compound in the tissue tested and gains particular significance when a mutagenic potential of the test compound has already been demonstrated in vitro. Such findings will have practical consequences in the risk assessment processes and further development of substances.
authors.affiliation: Federal Institute for Drugs and Medical Devices, Bonn, Germany.
authors.forename: Susanne
authors.initials: S
authors.lastname: Brendler-Schwaab
authors.forename: Andreas
authors.initials: A
authors.lastname: Hartmann
authors.forename: Stefan
authors.initials: S
authors.lastname: Pfuhler
authors.forename: Günter
authors.initials: G
authors.lastname: Speit
mesh_terms: D000818:Animals; D020552:Comet Assay / Q000379:methods*; D004249:DNA Damage; D017408:Guidelines as Topic; D006801:Humans; D009152:Mutagenicity Tests / Q000379:methods; D018570:Risk Assessment